A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System
Clinical trial NCT01775397 · TERMINATED
Trial details
- NCT number
- NCT01775397
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-29
- Primary completion
- 2013-04-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.